Primary results of SOLTI-1402/CORALLEEN phase 2 trial of neoadjuvant ribociclib plus letrozole versus chemotherapy in PAM50 Luminal B early breast cancer: An open-label, multicenter, two-arm, randomized study - Gavilá, J; Saura, C; Pascual, T (San Antonio Breast Cancer Symposium, 2019)
et al.